Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for dystrophies primarily involving the retinal pigment epithelium.
7 publications have been identified in PubMed for dystrophies primarily involving the retinal pigment epithelium. Research spans Gene Therapy / Novel Therapeutics (43%), Other (14%), and Review / Meta-Analysis (14%).
Kinane C (2026). [PMID: 41891763](https://pubmed.ncbi.nlm.nih.gov/41891763/). *Invest Ophthalmol Vis Sci*. [Gene Therapy / Novel Therapeutics]
Ahmed H (2026). [PMID: 35881734](https://pubmed.ncbi.nlm.nih.gov/35881734/). *Unknown Journal*. [Review / Meta-Analysis]
Chen KY (2026). [PMID: 42180403](https://pubmed.ncbi.nlm.nih.gov/42180403/). *EClinicalMedicine*. [Gene Therapy / Novel Therapeutics]
Suzuki T (2025). [PMID: 41405093](https://pubmed.ncbi.nlm.nih.gov/41405093/). *Investigative ophthalmology & visual science*. [Basic Science / Preclinical]
Dulken BW (2024). [PMID: 38802997](https://pubmed.ncbi.nlm.nih.gov/38802997/). *The American journal of surgical pathology*. [Other]
Onishi A (2024). [PMID: 39556087](https://pubmed.ncbi.nlm.nih.gov/39556087/). *Investigative ophthalmology & visual science*. [Gene Therapy / Novel Therapeutics]
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 3:47 AM UTC
Zou H (2024). [PMID: 38860019](https://pubmed.ncbi.nlm.nih.gov/38860019/). *Oxford medical case reports*. [Case Report / Case Series]